Lanford RE et al. |
Comparison of tamarins and marmosets as hosts for GBV-B infections and the effect of immunosuppression on duration of viremia. |
2003 |
Virology |
pmid:12832204
|
Franke EK and Luban J |
Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. |
1996 |
Virology |
pmid:8806510
|
Mahalingam R et al. |
Simian varicella virus reactivation in cynomolgus monkeys. |
2007 |
Virology |
pmid:17651776
|
Goldfeld AE et al. |
Cyclosporin A and FK506 block induction of the Epstein-Barr virus lytic cycle by anti-immunoglobulin. |
1995 |
Virology |
pmid:7538254
|
MistrÃková J et al. |
Increased neoplasm development due to immunosuppressive treatment with FK-506 in BALB/C mice persistently infected with the mouse herpesvirus (MHV-72). |
1999 |
Viral Immunol. |
pmid:10532652
|
Gambarino S et al. |
Human Cytomegalovirus Impact on mir-146a Expression Levels in Kidney Transplant Patients. |
2016 |
Viral Immunol. |
pmid:27077822
|
Shen ZY et al. |
Variations in the S and P regions of the hepatitis B virus genome under immunosuppression in vitro and in vivo. |
2012 |
Viral Immunol. |
pmid:22946668
|
Mortola E et al. |
The use of two immunosuppressive drugs, cyclosporin A and tacrolimus, to inhibit virus replication and apoptosis in cells infected with feline immunodeficiency virus. |
1998 |
Vet. Res. Commun. |
pmid:10066129
|
Tanaka Y et al. |
Suppression of feline coronavirus replication in vitro by cyclosporin A. |
2012 |
Vet. Res. |
pmid:22546085
|
Kano R et al. |
Treatment of sterile panniculitis in a dog. |
2004 |
Vet. Rec. |
pmid:15134169
|
Ofri R et al. |
Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A. |
2009 |
Vet. J. |
pmid:17950639
|
Sestak K et al. |
Tacrolimus-FK506 induced immunosuppression in gnotobiotic piglets. |
2000 |
Vet. Immunol. Immunopathol. |
pmid:11137126
|
Marsella R et al. |
Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study. |
2004 |
Vet. Dermatol. |
pmid:15500481
|
Mauldin EA et al. |
Proliferative and necrotizing otitis externa in four cats. |
2007 |
Vet. Dermatol. |
pmid:17845627
|
Banovic F et al. |
Tacrolimus therapy for dermal arteritis of the nasal philtrum refractory to surgery and anti-inflammatory therapy (doxycycline/niacinamide and topical fluocinolone) in a dog. |
2018 |
Vet. Dermatol. |
pmid:28990239
|
Hilton H et al. |
Evaluation of four topical preparations for the treatment of cannon hyperkeratosis in a horse. |
2008 |
Vet. Dermatol. |
pmid:19055613
|
Marsella R and Nicklin CF |
Investigation on the use of 0.3% tacrolimus lotion for canine atopic dermatitis: a pilot study. |
2002 |
Vet. Dermatol. |
pmid:12174182
|
Banovic F et al. |
Therapeutic effectiveness of calcineurin inhibitors in canine vesicular cutaneous lupus erythematosus. |
2017 |
Vet. Dermatol. |
pmid:28439997
|
Rosenkrantz WS |
Pemphigus: current therapy. |
2004 |
Vet. Dermatol. |
pmid:15030557
|
Olivry T et al. |
Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. |
2010 |
Vet. Dermatol. |
pmid:20456716
|
Marsella R et al. |
Investigation on the effects of topical therapy with 0.1% tacrolimus ointment (Protopic) on intradermal skin test reactivity in atopic dogs. |
2004 |
Vet. Dermatol. |
pmid:15305928
|
Lehner GM and Linek M |
A case of vesicular cutaneous lupus erythematosus in a Border collie successfully treated with topical tacrolimus and nicotinamide-tetracycline. |
2013 |
Vet. Dermatol. |
pmid:24118370
|
Kelley LS et al. |
Safety and tolerability of 0.1% tacrolimus solution applied to the external ear canals of atopic beagle dogs without otitis. |
2010 |
Vet. Dermatol. |
pmid:20609208
|
Bensignor E and Olivry T |
Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial. |
2005 |
Vet. Dermatol. |
pmid:15725106
|
Scholz FM et al. |
Focal metatarsal fistulae syndrome affecting a greyhound dog successfully treated with topical 0.1% tacrolimus ointment. |
2015 |
Vet. Dermatol. |
pmid:26216245
|
Nell B et al. |
The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: results from an exploratory study. |
2005 Jan-Feb |
Vet Ophthalmol |
pmid:15644099
|
Berdoulay A et al. |
Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca. |
2005 Jul-Aug |
Vet Ophthalmol |
pmid:16008701
|
Hafizi S et al. |
Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling. |
2004 May-Jun |
Vascul. Pharmacol. |
pmid:15607500
|
Dissemond J et al. |
Successful treatment of stasis dermatitis with topical tacrolimus. |
2004 |
VASA |
pmid:15623206
|
Woodward RS et al. |
The long-term outcomes and costs of diabetes mellitus among renal transplant recipients: tacrolimus versus cyclosporine. |
2011 |
Value Health |
pmid:21315636
|
Christ B et al. |
Interactions of sildenafil and tacrolimus in men with erectile dysfunction after kidney transplantation. |
2001 |
Urology |
pmid:11597545
|
Harmon JD et al. |
Stuttering priapism in a liver transplant patient with toxic levels of fk506. |
1999 |
Urology |
pmid:10754131
|
Chkhotua AB et al. |
Kidney transplantation from living-unrelated donors: comparison of outcome with living-related and cadaveric transplants under current immunosuppressive protocols. |
2003 |
Urology |
pmid:14665344
|
Ebert AK et al. |
[Topical therapy of balanitis xerotica obliterans in childhood. Long-term clinical results and an overview]. |
2007 |
Urologe A |
pmid:17994212
|
|
[Tacrolimus--a new perspective in kidney transplantation]. |
1996 |
Urologe A |
pmid:9022401
|
Nomura T et al. |
Enhancement by cyclosporin A of taxol-induced apoptosis of human urinary bladder cancer cells. |
2002 |
Urol. Res. |
pmid:12086014
|
Hwang MT and Goldfarb DS |
Uric acid stones following hepatic transplantation. |
2004 |
Urol. Res. |
pmid:15565437
|
Veroux P et al. |
Severe neurotoxicity in tacrolimus-treated living kidney transplantation in two cases. |
2003 |
Urol. Int. |
pmid:14646448
|
Pichler R et al. |
De novo renal cell carcinoma in a kidney allograft with focus on contrast-enhanced ultrasound. |
2014 |
Urol. Int. |
pmid:25115614
|
Naderi GH et al. |
Tacrolimus rescue therapy for corticosteroid-resistant and polyclonal antibody-resistant kidney allograft rejections. |
2009 |
Urol J |
pmid:19241339
|
Freire A et al. |
Comparison of blood tacrolimus concentrations in liver and kidney transplant recipients using ACMIA and MEIA immunoassays. |
2008 |
Ups. J. Med. Sci. |
pmid:18521804
|
Präst I et al. |
Nerve cells in transplanted pancreatic islets: no effects of cyclosporin or tacrolimus on immediate neuronal survival. |
2001 |
Ups. J. Med. Sci. |
pmid:11888070
|
Valesky EM et al. |
[Postoperative pyoderma gangrenosum of Cullen]. |
2007 |
Unfallchirurg |
pmid:17786400
|
Deleuran M et al. |
[Topical immune modulation and risk of cancer]. |
2009 |
Ugeskr. Laeg. |
pmid:19732533
|
Rosenzweig M |
[Prescription of topical immunomodulators]. |
2009 |
Ugeskr. Laeg. |
pmid:19732534
|
Thestrup-Pedersen K and Thomsen TF |
[Creams used in the treatment of children can cause cancer]. |
2005 |
Ugeskr. Laeg. |
pmid:15832731
|
Tusgaard Petersen B et al. |
[Family occurrence of steroid-sensitive idiopathic nephrotic syndrome]. |
2012 |
Ugeskr. Laeg. |
pmid:23153469
|
Mørtz CG and Deleuran MS |
[A case of childhood granulomatous perioral dermatitis (CGPD) in a three year old boy from Madagascar]. |
2008 |
Ugeskr. Laeg. |
pmid:18252166
|
Tümgör G et al. |
Fatty liver due to high levels of serum tacrolimus after liver transplantation. |
2007 Apr-Jun |
Turk. J. Pediatr. |
pmid:17907528
|
Ismailoglu O et al. |
Topical application of tacrolimus prevents epidural fibrosis in a rat postlaminectomy model: histopathological and ultrastructural analysis. |
2011 |
Turk Neurosurg |
pmid:22194127
|
Tümgör G et al. |
A case of uneventful ABO-incompatible liver transplantation from a deceased donor managed with routine immunosuppressive treatment. |
2014 |
Turk J Gastroenterol |
pmid:25599790
|
Dinçkan A et al. |
Evaluation of the first 100 liver transplantations. |
2008 |
Turk J Gastroenterol |
pmid:18386237
|
Bajetta E et al. |
Merkel cell carcinoma after liver transplantation: a case report. |
2007 May-Jun |
Tumori |
pmid:17679476
|
Vennarecci G et al. |
[Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)]. |
2003 Jul-Aug |
Tumori |
pmid:12903579
|
Sommerer C et al. |
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:26888217
|
Nashan B et al. |
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. |
2015 |
Trials |
pmid:25873064
|
Snyder SH et al. |
Neural actions of immunophilin ligands. |
1998 |
Trends Pharmacol. Sci. |
pmid:9509898
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
Chang JY et al. |
FK506 and rapamycin: novel pharmacological probes of the immune response. |
1991 |
Trends Pharmacol. Sci. |
pmid:1710854
|
Cardenas ME et al. |
Signal-transduction cascades as targets for therapeutic intervention by natural products. |
1998 |
Trends Biotechnol. |
pmid:9807840
|
Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
|
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Drug levels in PHAs who receive liver transplants. |
2003 Apr-May |
TreatmentUpdate |
pmid:17216847
|
Qi S et al. |
Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates. |
2003 |
Transplantation |
pmid:12717189
|
Abbott KC et al. |
New-onset gout after kidney transplantation: incidence, risk factors and implications. |
2005 |
Transplantation |
pmid:16340779
|
Han DH et al. |
Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene. |
2010 |
Transplantation |
pmid:20562737
|
Maruyama M et al. |
Effect of FK506 treatment on allocytolytic T lymphocyte induction in vivo: differential effects of FK506 on L3T4+ and Ly2+ T cells. |
1990 |
Transplantation |
pmid:1696410
|
Sampaio MS et al. |
Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients. |
2012 |
Transplantation |
pmid:22129761
|
Winkler ME et al. |
Successful pregnancy in a patient after liver transplantation maintained on FK 506. |
1993 |
Transplantation |
pmid:7506460
|
Garcia-Criado FJ et al. |
Possible tacrolimus action mechanisms in its protector effects on ischemia-reperfusion injury. |
1998 |
Transplantation |
pmid:9798713
|
Mack-Shipman LR et al. |
Reproductive hormones after pancreas transplantation. |
2000 |
Transplantation |
pmid:11063337
|
Suzuki S et al. |
Pure red cell aplasia induced by FK506. |
1996 |
Transplantation |
pmid:8607191
|
Mourad G et al. |
Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial. |
2017 |
Transplantation |
pmid:27547871
|
Gaber AO et al. |
Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. |
2008 |
Transplantation |
pmid:19005398
|
Atkison PR et al. |
Arteritis and increased intracellular calcium as a possible mechanism for tacrolimus-related cardiac toxicity in a pediatric transplant recipient. |
1997 |
Transplantation |
pmid:9311719
|
Baid-Agrawal S et al. |
Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients. |
2004 |
Transplantation |
pmid:15114085
|
Lang T et al. |
Cholic acid synthesis is reduced in pediatric liver recipients during graft dysfunction due to ischemic injury and allograft rejection. |
1997 |
Transplantation |
pmid:9415561
|
Marino IR et al. |
Efficacy and safety of basiliximab with a tacrolimus-based regimen in liver transplant recipients. |
2004 |
Transplantation |
pmid:15385809
|
Stevens RB et al. |
A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes. |
2015 |
Transplantation |
pmid:25083614
|
McDevitt-Potter LM et al. |
A multicenter experience with generic tacrolimus conversion. |
2011 |
Transplantation |
pmid:21788920
|
Gill JS et al. |
Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection. |
2010 |
Transplantation |
pmid:20098280
|
Ravaioli M et al. |
Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial. |
2015 |
Transplantation |
pmid:25757214
|
Pascual J et al. |
Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation. |
2009 |
Transplantation |
pmid:19136902
|
Krook H et al. |
Immunosuppressive drugs in islet xenotransplantation: a tool for gaining further insights in the mechanisms of the rejection process. |
2002 |
Transplantation |
pmid:12438951
|
Blaheta RA et al. |
Mycophenolate mofetil decreases endothelial prostaglandin E2 in response to allogeneic T cells or cytokines. |
2000 |
Transplantation |
pmid:10830246
|
Vafadari R et al. |
Inhibitory effect of tacrolimus on p38 mitogen-activated protein kinase signaling in kidney transplant recipients measured by whole-blood phosphospecific flow cytometry. |
2012 |
Transplantation |
pmid:22643331
|
Markus PM et al. |
Effects of in vivo treatment with FK506 on natural killer cells in rats. |
1991 |
Transplantation |
pmid:1707562
|
Morales JM et al. |
Improved renal function, with similar proteinuria, after two years of early tacrolimus withdrawal from a regimen of sirolimus plus tacrolimus. |
2008 |
Transplantation |
pmid:18724234
|
Gallon LG et al. |
Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. |
2007 |
Transplantation |
pmid:17519781
|
Higgins R et al. |
Rises and falls in donor-specific and third-party HLA antibody levels after antibody incompatible transplantation. |
2009 |
Transplantation |
pmid:19300192
|
Steiner RW |
Steroid withdrawal in kidney transplantation: the subgroup fallacy. |
2011 |
Transplantation |
pmid:21336084
|
Jain AB et al. |
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. |
2003 |
Transplantation |
pmid:14501862
|
Vathsala A et al. |
The immunosuppressive antagonism of low doses of FK506 and cyclosporine. |
1991 |
Transplantation |
pmid:1713361
|
Ueki S et al. |
Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin. |
2006 |
Transplantation |
pmid:17198266
|
Ogawa H et al. |
Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation. |
2002 |
Transplantation |
pmid:12151737
|
MacDonald AS |
Impact of immunosuppressive therapy on hypertension. |
2000 |
Transplantation |
pmid:11152235
|
Sher LS et al. |
Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group. |
1997 |
Transplantation |
pmid:9256184
|
Younes BS et al. |
The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients. |
2000 |
Transplantation |
pmid:10919581
|
Higgins RM et al. |
Conversion from tacrolimus to cyclosporin in stable renal transplant patients: safety, metabolic changes, and pharmacokinetic comparison. |
2000 |
Transplantation |
pmid:10919600
|
Cherikh WS et al. |
A comparison of discharge immunosuppressive drug regimens in primary cadaveric kidney transplantation. |
2003 |
Transplantation |
pmid:12923430
|
Zieliński A et al. |
Simultaneous pancreas-kidney transplant from living related donor: a single-center experience. |
2003 |
Transplantation |
pmid:12923442
|